N-terminal-probrain natriuretic peptide as a biomarker of moderate to severe bronchopulmonary dysplasia in preterm infants: A prospective observational study.

Silvia Rodríguez-BlancoIgnacio Oulego-ErrozPaula Alonso-QuintelaSandra Terroba-SearaAquilina Jiménez-GonzálezMaite Palau-Benavides

Published in: Pediatric pulmonology (2018)

The NT-proBNP levels at 5-10 days of life may identify preterm infants with an HsPDA who are at high risk of BPD or death and may be useful for individualized preventive and therapeutic strategies.

Keyphrases

preterm infants
low birth weight
high intensity
early onset